FDA Scraps Trump-HHS Mandate To Publish Drug Review Timelines

By Beth Wang / May 3, 2021 at 12:17 PM
The Biden administration on Friday (April 30) withdrew an eleventh-hour Trump-era policy that would have required FDA to publish review timelines for certain drug product applications. HHS and FDA say they’re revoking the Trump administration’s policy, which was signed by former HHS Secretary Alex Azar, because it didn’t take into consideration all the information that is already publicly available about FDA’s review of drug applications. At issue is an HHS policy that would have required FDA to annually publish information...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.